The FDA approved the US’ first over-the-counter birth control pill. What happens next?
Board Chair Dr. Kristyn Brandi discusses the many benefits of how Opill’s over-the-counter availability.
Board Chair Dr. Kristyn Brandi discusses the many benefits of how Opill’s over-the-counter availability.
Our Fellow Chelsea Thibodeau shares how making Opill available over the counter is an “excellent and appropriate move…”
Current fellow Dr. Katherine Farris spoke with Cosmo to share the facts about Plan B.
The Winston-Salem Journal published current fellow Dr. Katherine Farris’ letter to the editor this past weekend. In her letter, Dr. Farris highlights how the Trump […]
Women’s Media Center spoke to current Fellow Dr. Tiffany Hailstorks extensively about what the new Title X rules mean for reproductive rights.
Governing mentioned Physicians for Reproductive Health in a piece about several states vowing to sue the Trump administration over the final Title X gag rule.
Rewire featured our statement from Academy alum Dr. Meera Shah for a story about the GOP Senate prioritizing abortion coverage ban over ending the government […]
NJBiz included Physicians for Reproductive Health as part of a cohort of organizations who submitted amicus briefs in New Jersey and Pennsylvania to block Trump’s […]